← Back to Search

Behavioural Intervention

Personalized Feedback for Cancer Survivor Physical Activity (Project KNOWN Trial)

Led By Yue Liao, MPH, PhD
Research Sponsored by The University of Texas at Arlington
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Screening 3 weeks
Treatment Varies
Follow Up through study completion, an average of 3 months.
Awards & highlights

Project KNOWN Trial Summary

This trial is looking at how to get cancer survivors who are at high risk for type 2 diabetes to be more physically active using personalized feedback.

Who is the study for?
This trial is for cancer survivors over 18, who've finished treatment at least 3 months ago and are at high risk for type 2 diabetes due to inactivity. Participants must speak English, have a smartphone with internet, and be able to exercise moderately without supervision. Those on certain insulin treatments, other health programs, incompatible smartphones, pregnant women, dialysis patients, overnight workers or those with activity-limiting health issues can't join.Check my eligibility
What is being tested?
The study tests if real-time glucose feedback from wearable devices motivates physical activity in inactive cancer survivors at risk of type 2 diabetes. It compares standard feedback against glucose-based biofeedback using continuous monitors and tracks daily activity levels to see the immediate effects of exercise on biological status.See study design
What are the potential side effects?
Since this trial involves non-invasive monitoring through wearables rather than medication or invasive procedures, significant side effects are not expected. However, participants may experience discomfort or skin irritation from wearing the devices.

Project KNOWN Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~through study completion, an average of 3 months.
This trial's timeline: 3 weeks for screening, Varies for treatment, and through study completion, an average of 3 months. for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Feasibility of delivering personalized glucose-based feedback
Secondary outcome measures
Changes in daily physical activity level

Project KNOWN Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Biofeedback GroupExperimental Treatment2 Interventions
Group II: Standard Care GroupActive Control1 Intervention
First Studied
Drug Approval Stage
How many patients have taken this drug
Glucose monitoring

Find a Location

Who is running the clinical trial?

The University of Texas at ArlingtonLead Sponsor
43 Previous Clinical Trials
4,888 Total Patients Enrolled
American Institute for Cancer ResearchOTHER
10 Previous Clinical Trials
8,511 Total Patients Enrolled
Yue Liao, MPH, PhDPrincipal InvestigatorUniversity of Texas at Arlington

Media Library

Glucose-based biofeedback (Behavioural Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT05490641 — N/A
Cancer Research Study Groups: Biofeedback Group, Standard Care Group
Cancer Clinical Trial 2023: Glucose-based biofeedback Highlights & Side Effects. Trial Name: NCT05490641 — N/A
Glucose-based biofeedback (Behavioural Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05490641 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any available spots for this research project?

"This research is actively seeking participants, as evidenced by the postings of clinicaltrials.gov. The trial was first advertised on January 15th 2023 and has since been updated most recently in October 28th 2022."

Answered by AI

How many participants are being admitted to this trial?

"Affirmative. Details available on clinicaltrials.gov demonstrate that this investigation is proactively searching for participants and has been since January 15th of 2023, with a most recent update taking place on October 28th 2022. The trial seeks to recruit 50 individuals from one location."

Answered by AI
~15 spots leftby Dec 2024